IGFBP2 and cranial nerve palsy: Regarding cranial nerve paralysis, elevation of ErbB3 (OR: 1.1468, 95% CI: 1.0025-1.3118, PIVW: 0.0458) and IL-6R (OR: 1.2062, 95% CI: 1.0046-1.4481, PIVW: 0.0445) was linked to an increased risk, whereas an increase in IGFBP-2 (OR: 0.8035, 95% CI: 0.6802-0.9490, PIVW: 0.0100) was associated with a decreased risk.